Menu
Apart from Fibrinolytic drugs antiplatelets and anticoagulants there are many other drugs which have a role to play in the management of STEMI.
Beta-blockers, RAAS blockers and ARNI are the drugs which are disease-modifying and improve outcomes and reduce disease mortality in MI patients in STEMI cases.
MBBS, MD - General Medicine, DM - Cardiology, FRCP Cardiologist, Interventional Cardiologist
Apart from Fibrinolytic drugs antiplatelets and anticoagulants there are many other drugs which have a role to play in the management of STEMI.
Beta-blockers, RAAS blockers and ARNI are the drugs which are disease-modifying and improve outcomes and reduce disease mortality in MI patients in STEMI cases.
MBBS, MD – General Medicine, DM – Cardiology, FRCP Cardiologist, Interventional Cardiologist